Skip to menu Skip to content Skip to footer

2020

Journal Article

COVID-19: A critical care perspective informed by lessons learnt from other viral epidemics

Ling, Lowell, Joynt, Gavin M., Lipman, Jeff, Constantin, Jean-Michel and Joannes-Boyau, Olivier (2020). COVID-19: A critical care perspective informed by lessons learnt from other viral epidemics. Anaesthesia Critical Care & Pain Medicine, 39 (2), 163-166. doi: 10.1016/j.accpm.2020.02.002

COVID-19: A critical care perspective informed by lessons learnt from other viral epidemics

2020

Journal Article

Prophylactic cefazolin dosing in women with body mass index >35 kg·m−2 undergoing cesarean delivery : a pharmacokinetic study of plasma and interstitial fluid

Eley, Victoria A., Christensen, Rebecca, Ryan, Rochelle, Jackson, Dwane, Parker, Suzanne L., Smith, Matthew, van Zundert, Andre A., Wallis, Steven C., Lipman, Jeffrey and Roberts, Jason A. (2020). Prophylactic cefazolin dosing in women with body mass index >35 kg·m−2 undergoing cesarean delivery : a pharmacokinetic study of plasma and interstitial fluid. Anesthesia and Analgesia, 131 (1), 1-207. doi: 10.1213/ane.0000000000004766

Prophylactic cefazolin dosing in women with body mass index >35 kg·m−2 undergoing cesarean delivery : a pharmacokinetic study of plasma and interstitial fluid

2020

Journal Article

New guidelines for the management of severe thermal burns in the acute phase in adults and children: Is it time for a global surviving burn injury campaign (SBIC)?

Holley, Anthony, Cohen, Jeremy, Reade, Michael, Laupland, Kevin B. and Lipman, Jeffrey (2020). New guidelines for the management of severe thermal burns in the acute phase in adults and children: Is it time for a global surviving burn injury campaign (SBIC)?. Anaesthesia Critical Care and Pain Medicine, 39 (2), 195-196. doi: 10.1016/j.accpm.2020.03.009

New guidelines for the management of severe thermal burns in the acute phase in adults and children: Is it time for a global surviving burn injury campaign (SBIC)?

2020

Journal Article

Development of Population and Bayesian Models for Applied Use in Patients Receiving Cefepime

Liu, Jiajun, Neely, Michael, Lipman, Jeffrey, Sime, Fekade, Roberts, Jason A., Kiel, Patrick J., Avedissian, Sean N., Rhodes, Nathaniel J. and Scheetz, Marc H. (2020). Development of Population and Bayesian Models for Applied Use in Patients Receiving Cefepime. Clinical Pharmacokinetics, 59 (8), 1027-1036. doi: 10.1007/s40262-020-00873-3

Development of Population and Bayesian Models for Applied Use in Patients Receiving Cefepime

2020

Journal Article

β-lactam antibiotic versus combined β-lactam antibiotic and single-daily dosing regimens of aminoglycosides for the treatment of serious infections: a meta-analysis

Heffernan, Aaron James, Sime, Fekade Bruck, Sun, Jing, Lipman, Jeffrey, Kumar, Anand, Andrews, Katherine, Ellwood, David, Grimwood, Keith and Roberts, Jason (2020). β-lactam antibiotic versus combined β-lactam antibiotic and single-daily dosing regimens of aminoglycosides for the treatment of serious infections: a meta-analysis. International Journal of Antimicrobial Agents, 55 (3) 105839, 105839. doi: 10.1016/j.ijantimicag.2019.10.020

β-lactam antibiotic versus combined β-lactam antibiotic and single-daily dosing regimens of aminoglycosides for the treatment of serious infections: a meta-analysis

2020

Journal Article

Amoxicillin-clavulanate dosing in the intensive care unit: the additive effect of renal replacement therapy in a patient with normal kidney function

Lonsdale, Dagan Osborne, Lipman, Jeffrey, Livermore, Amelia, McWhinney, Brett, Ungerer, Jacobus P.J. and Roberts, Jason A. (2020). Amoxicillin-clavulanate dosing in the intensive care unit: the additive effect of renal replacement therapy in a patient with normal kidney function. Chemotherapy, 64 (4), 1-4. doi: 10.1159/000505057

Amoxicillin-clavulanate dosing in the intensive care unit: the additive effect of renal replacement therapy in a patient with normal kidney function

2020

Journal Article

Antimicrobial de-escalation is part of appropriate antibiotic usage in ICU

Timsit, Jean-Francois, Lipman, Jeffrey and Bassetti, Matteo (2020). Antimicrobial de-escalation is part of appropriate antibiotic usage in ICU. Intensive Care Medicine, 46 (5), 1039-1042. doi: 10.1007/s00134-020-05951-5

Antimicrobial de-escalation is part of appropriate antibiotic usage in ICU

2020

Journal Article

β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill

Wong, Gloria, Taccone, Fabio, Villois, Paola, Scheetz, Marc H., Rhodes, Nathaniel J., Briscoe, Scott, McWhinney, Brett, Nunez-Nunez, Maria, Ungerer, Jacobus, Lipman, Jeffrey and Roberts, Jason A. (2020). β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill. Journal of Antimicrobial Chemotherapy, 75 (2), 429-433. doi: 10.1093/jac/dkz437

β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill

2020

Journal Article

Ventilator-Associated Tracheobronchitis: To Treat or Not to Treat?

Koulenti, Despoina, Arvaniti, Kostoula, Judd, Mathew, Lalos, Natasha, Tjoeng, Iona, Xu, Elena, Armaganidis, Apostolos and Lipman, Jeffrey (2020). Ventilator-Associated Tracheobronchitis: To Treat or Not to Treat?. Antibiotics, 9 (2) 51, 51. doi: 10.3390/antibiotics9020051

Ventilator-Associated Tracheobronchitis: To Treat or Not to Treat?

2020

Journal Article

Emerging treatment options for infections by multidrug-resistant gram-positive microorganisms

Koulenti, Despoina, Xu, Elena, Song, Andrew, Mok, Isaac Yin Sum , Karageorgopoulos, Drosos E., Armaganidis, Apostolos, Tsiodras, Sotirios and Lipman, Jeffrey (2020). Emerging treatment options for infections by multidrug-resistant gram-positive microorganisms. Microorganisms, 8 (2) 191, 1-40. doi: 10.3390/microorganisms8020191

Emerging treatment options for infections by multidrug-resistant gram-positive microorganisms

2020

Journal Article

Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaechei

Roberts, Leah W., Harris, Patrick N. A., Forde, Brian M., Ben Zakour, Nouri L., Catchpoole, Elizabeth, Stanton-Cook, Mitchell, Phan, Minh-Duy, Sidjabat, Hanna E., Bergh, Haakon, Heney, Claire, Gawthorne, Jayde A., Lipman, Jeffrey, Allworth, Anthony, Chan, Kok-Gan, Chong, Teik Min, Yin, Wai-Fong, Schembri, Mark A., Paterson, David L. and Beatson, Scott A. (2020). Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaechei. Nature Communications, 11 (1) 466, 466. doi: 10.1038/s41467-019-14139-5

Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaechei

2020

Journal Article

Erratum to ‘When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit’ [Clin Microbiol Infect 26 (1) (January 2020) 35–40](S1198743X19303969)(10.1016/j.cmi.2019.07.007)

Denny, K. J., De Waele, J., Laupland, K. B., Harris, P. N.A. and Lipman, J. (2020). Erratum to ‘When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit’ [Clin Microbiol Infect 26 (1) (January 2020) 35–40](S1198743X19303969)(10.1016/j.cmi.2019.07.007). Clinical Microbiology and Infection, 26 (6), 801-801. doi: 10.1016/j.cmi.2020.01.016

Erratum to ‘When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit’ [Clin Microbiol Infect 26 (1) (January 2020) 35–40](S1198743X19303969)(10.1016/j.cmi.2019.07.007)

2020

Journal Article

Antimicrobial-associated harm in critical care: a narrative review

Arulkumaran, Nishkantha, Routledge, Matthew, Schlebusch, Sanmarié, Lipman, Jeffrey and Conway Morris, Andrew (2020). Antimicrobial-associated harm in critical care: a narrative review. Intensive Care Medicine, 46 (2), 225-235. doi: 10.1007/s00134-020-05929-3

Antimicrobial-associated harm in critical care: a narrative review

2020

Journal Article

Meropenem-tobramycin combination regimens combat carbapenem-resistant Pseudomonas aeruginosa in the hollow-fiber infection model simulating augmented renal clearance in critically ill patients

Yadav, Rajbharan, Bergen, Phillip J., Rogers, Kate E., Kirkpatrick, Carl M. J., Wallis, Steven C., Huang, Yuling, Bulitta, Jürgen B., Paterson, David L., Lipman, Jeffrey, Nation, Roger L., Roberts, Jason A. and Landersdorfer, Cornelia B. (2020). Meropenem-tobramycin combination regimens combat carbapenem-resistant Pseudomonas aeruginosa in the hollow-fiber infection model simulating augmented renal clearance in critically ill patients. Antimicrobial Agents and Chemotherapy, 64 (1) e01679-19. doi: 10.1128/aac.01679-19

Meropenem-tobramycin combination regimens combat carbapenem-resistant Pseudomonas aeruginosa in the hollow-fiber infection model simulating augmented renal clearance in critically ill patients

2020

Journal Article

A population pharmacokinetic model-guided evaluation of ceftolozane/tazobactam dosing in critically ill patients undergoing continuous venovenous hemodiafiltration

Sime, Fekade B., Lassig-Smith, Melissa, Starr, Therese, Stuart, Janine, Pandey, Saurabh, Parker, Suzanne L., Wallis, Steven C., Lipman, Jeffrey and Roberts, Jason A. (2020). A population pharmacokinetic model-guided evaluation of ceftolozane/tazobactam dosing in critically ill patients undergoing continuous venovenous hemodiafiltration. Antimicrobial Agents and Chemotherapy, 64 (1) e01655. doi: 10.1128/aac.01655-19

A population pharmacokinetic model-guided evaluation of ceftolozane/tazobactam dosing in critically ill patients undergoing continuous venovenous hemodiafiltration

2020

Journal Article

Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsis

Fujii, Motoki, Karumai, Toshiyuki, Yamamoto, Ryohei, Kobayashi, Eri, Ogawa, Kenta, Tounai, Mayuko, Lipman, Jeffrey and Hayashi, Yoshiro (2020). Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsis. Expert Opinion on Drug Metabolism and Toxicology, 16 (5), 1-16. doi: 10.1080/17425255.2020.1750597

Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsis

2020

Journal Article

Pharmacokinetic/pharmacodynamic adequacy of polymyxin B against extensively drug-resistant Gram-negative bacteria in critically ill, general ward and cystic fibrosis patient populations

Xie, Jiao, Roberts, Jason A., Lipman, Jeffrey, Cai, Yan, Wang, Haitao, Zhao, Nuannuan, Xu, Xiaona, Yang, Shan, Li, Youjia and Zhang, Kanghuai (2020). Pharmacokinetic/pharmacodynamic adequacy of polymyxin B against extensively drug-resistant Gram-negative bacteria in critically ill, general ward and cystic fibrosis patient populations. International Journal of Antimicrobial Agents, 55 (6) 105943, 105943. doi: 10.1016/j.ijantimicag.2020.105943

Pharmacokinetic/pharmacodynamic adequacy of polymyxin B against extensively drug-resistant Gram-negative bacteria in critically ill, general ward and cystic fibrosis patient populations

2020

Journal Article

When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit

Denny, K. J., De Waele, J., Laupland, K. B., Harris, P. N. A. and Lipman, J. (2020). When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit. Clinical Microbiology and Infection, 26 (1), 35-40. doi: 10.1016/j.cmi.2019.07.007

When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit

2019

Journal Article

Survey of critical care practice in Australian and New Zealand burn referral centres

Holley, Anthony D., Reade, Michael C., Lipman, Jeffrey, Delaney, Anthony, Udy, Andrew, Lee, Richard, Litton, Edward, Cheung, Winston, Turner, Andrew, Garside, Tessa, Macken, Lewis, Reddi, Benjamin, Kol, Mark, Kazemi, Alex, Shah, Asim, Townsend, Shane and Cohen, Jeremy (2019). Survey of critical care practice in Australian and New Zealand burn referral centres. Critical Care and Resuscitation, 21 (4), 303-304.

Survey of critical care practice in Australian and New Zealand burn referral centres

2019

Journal Article

Saturable elimination of piperacillin in critically ill patients: implications for continuous infusion

Dhaese, S.A.M., Colin, P., Willems, H., Heffernan, A., Gadeyne, B., Van Vooren, S., Depuydt, P., Hoste, E., Stove, V., Verstraete, A.G., Lipman, J., Roberts, J.A. and De Waele, J.J. (2019). Saturable elimination of piperacillin in critically ill patients: implications for continuous infusion. International Journal of Antimicrobial Agents, 54 (6), 741-749. doi: 10.1016/j.ijantimicag.2019.08.024

Saturable elimination of piperacillin in critically ill patients: implications for continuous infusion